Gary Dever

Gary Dever has extensive work experience in the field of medical communications and scientific research.

Gary started their career at Envision Pharma Group in 2019 where they initially served as the Scientific Director and Team Lead until the end of 2019. From January 2020 onwards, they held the position of VP, Portfolio Director & Team Lead.

Prior to their time at Envision Pharma Group, Gary worked at Complete Medical Communications from 2009 to 2018. During their tenure, they held various roles including Scientific Director, Scientific Team Leader, Senior Medical Writer, and Medical Writer, demonstrating their expertise in medical writing and leadership.

Before transitioning to the medical communications industry, Gary gained research experience as a Postdoctoral Research Scientist at the University of Glasgow from 2007 to 2009.

Gary's academic journey began at the University of Strathclyde in 2002, where they served as a Graduate Teaching Associate until 2006.

Overall, Gary Dever has a strong background in scientific research and medical communications, with notable experience in leadership and portfolio management.

Gary Dever obtained a BSc (Hons) in Biochemistry and Pharmacology from the University of Strathclyde, where they studied from 1998 to 2002. Gary then pursued further education and earned a PhD in Cardiovascular Science from the same university, completing their doctoral studies from 2002 to 2006. In addition to their formal education, Gary Dever has obtained a certification in ISMPP CMPP, although specific details regarding the institution and the year of certification are unavailable.